Postpartum depression: psychoneuroimmunological underpinnings and treatment

George Anderson,1 Michael Maes21CRC Clincial Research Centre/Communications, Glasgow, Scotland; 2Department of Psychiatry, Chulalongkorn University, Bangkok, ThailandAbstract: Postpartum depression (PPD) is common, occurring in 10%–15% of women. Due to concerns about teratogenicity of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anderson G, Maes M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://doaj.org/article/0f7d2b9972f049ce8cf55e9e5ce04948
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0f7d2b9972f049ce8cf55e9e5ce04948
record_format dspace
spelling oai:doaj.org-article:0f7d2b9972f049ce8cf55e9e5ce049482021-12-02T06:23:20ZPostpartum depression: psychoneuroimmunological underpinnings and treatment1176-63281178-2021https://doaj.org/article/0f7d2b9972f049ce8cf55e9e5ce049482013-02-01T00:00:00Zhttp://www.dovepress.com/postpartum-depression-psychoneuroimmunological-underpinnings-and-treat-a12280https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021George Anderson,1 Michael Maes21CRC Clincial Research Centre/Communications, Glasgow, Scotland; 2Department of Psychiatry, Chulalongkorn University, Bangkok, ThailandAbstract: Postpartum depression (PPD) is common, occurring in 10%–15% of women. Due to concerns about teratogenicity of medications in the suckling infant, the treatment of PPD has often been restricted to psychotherapy. We review here the biological underpinnings to PPD, suggesting a powerful role for the tryptophan catabolites, indoleamine 2,3-dixoygenase, serotonin, and autoimmunity in mediating the consequences of immuno-inflammation and oxidative and nitrosative stress. It is suggested that the increased inflammatory potential, the decreases in endogenous anti-inflammatory compounds together with decreased omega-3 poly-unsaturated fatty acids, in the postnatal period cause an inflammatory environment. The latter may result in the utilization of peripheral inflammatory products, especially kynurenine, in driving the central processes producing postnatal depression. The pharmacological treatment of PPD is placed in this context, and recommendations for more refined and safer treatments are made, including the better utilization of the antidepressant, and the anti-inflammatory and antioxidant effects of melatonin.Keywords: SSRI, kynurenine, IDO, TDO, melatoninAnderson GMaes MDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 277-287 (2013)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Anderson G
Maes M
Postpartum depression: psychoneuroimmunological underpinnings and treatment
description George Anderson,1 Michael Maes21CRC Clincial Research Centre/Communications, Glasgow, Scotland; 2Department of Psychiatry, Chulalongkorn University, Bangkok, ThailandAbstract: Postpartum depression (PPD) is common, occurring in 10%–15% of women. Due to concerns about teratogenicity of medications in the suckling infant, the treatment of PPD has often been restricted to psychotherapy. We review here the biological underpinnings to PPD, suggesting a powerful role for the tryptophan catabolites, indoleamine 2,3-dixoygenase, serotonin, and autoimmunity in mediating the consequences of immuno-inflammation and oxidative and nitrosative stress. It is suggested that the increased inflammatory potential, the decreases in endogenous anti-inflammatory compounds together with decreased omega-3 poly-unsaturated fatty acids, in the postnatal period cause an inflammatory environment. The latter may result in the utilization of peripheral inflammatory products, especially kynurenine, in driving the central processes producing postnatal depression. The pharmacological treatment of PPD is placed in this context, and recommendations for more refined and safer treatments are made, including the better utilization of the antidepressant, and the anti-inflammatory and antioxidant effects of melatonin.Keywords: SSRI, kynurenine, IDO, TDO, melatonin
format article
author Anderson G
Maes M
author_facet Anderson G
Maes M
author_sort Anderson G
title Postpartum depression: psychoneuroimmunological underpinnings and treatment
title_short Postpartum depression: psychoneuroimmunological underpinnings and treatment
title_full Postpartum depression: psychoneuroimmunological underpinnings and treatment
title_fullStr Postpartum depression: psychoneuroimmunological underpinnings and treatment
title_full_unstemmed Postpartum depression: psychoneuroimmunological underpinnings and treatment
title_sort postpartum depression: psychoneuroimmunological underpinnings and treatment
publisher Dove Medical Press
publishDate 2013
url https://doaj.org/article/0f7d2b9972f049ce8cf55e9e5ce04948
work_keys_str_mv AT andersong postpartumdepressionpsychoneuroimmunologicalunderpinningsandtreatment
AT maesm postpartumdepressionpsychoneuroimmunologicalunderpinningsandtreatment
_version_ 1718399916477251584